ESSA Total Assets from 2010 to 2024

EPIX Stock

USD 1.79 0.02 1.10%

ESSA Pharma Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2013-09-30

Previous Quarter

137.9 M

Current Value

132.7 M

Quarterly Volatility

74.7 M

Yuan Drop

Covid

Check ESSA Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ESSA Pharma's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 5.9 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 272.8 K, Dividend Yield of 0.0 or PTB Ratio of 52.01. ESSA financial statements analysis is a perfect complement when working with ESSA Pharma Valuation or Volatility modules.

Check out the analysis of ESSA Pharma Correlation against competitors.

For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.

Latest ESSA Pharma's Total Assets Growth Pattern

Below is the plot of the Total Assets of ESSA Pharma over the last few years. Total assets refers to the total amount of ESSA Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ESSA Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. ESSA Pharma's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ESSA Pharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 149.12 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

ESSA Total Assets Regression Statistics

	Arithmetic Mean	69,872,087
	Geometric Mean	7,867,610
	Coefficient Of Variation	113.98
	Mean Deviation	70,625,447
	Median	16,017,000
	Standard Deviation	79,643,292
	Sample Variance	6343.1T
	Range	198.2M
	R-Value	0.89
	Mean Square Error	1379.9T
	R-Squared	0.80
	Slope	15,908,701
	Total Sum of Squares	88802.8T

ESSA Total Assets History

	2024	180.1 M
	2023	171.5 M
	2022	149.1 M
	2021	169.5 M
	2020	198.2 M
	2019	80.6 M
	2018	54.8 M

Other Fundumenentals of ESSA Pharma

Intangibles To Total Assets

ESSA Pharma Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Net Tangible Assets	Long Term Debt	Net Receivables	Property Plant Equipment	Net Invested Capital	Net Working Capital	Current Deferred Revenue	Capital Stock
Total Assets		1.0	-0.75	-0.95	0.27	-0.03	1.0	0.01	0.99	1.0	0.59	-0.15	0.63	0.97	0.97	0.51	0.96
Total Stockholder Equity	1.0		-0.75	-0.94	0.24	-0.07	1.0	0.0	0.98	1.0	0.57	-0.15	0.62	0.97	0.97	0.51	0.96
Net Debt	-0.75	-0.75		0.57	-0.12	0.02	-0.75	0.05	-0.64	-0.7	-0.43	0.07	-0.76	-0.79	-0.79	-0.03	-0.67
Retained Earnings	-0.95	-0.94	0.57		-0.35	-0.07	-0.95	-0.04	-0.97	-0.95	-0.67	0.18	-0.58	-0.92	-0.92	-0.52	-0.95
Accounts Payable	0.27	0.24	-0.12	-0.35		0.72	0.27	0.26	0.3	0.26	0.22	0.22	0.46	0.24	0.24	0.29	0.28
Total Liab	-0.03	-0.07	0.02	-0.07	0.72		-0.03	0.22	0.0	-0.06	0.42	-0.05	0.16	-0.08	-0.08	0.04	-0.09
Total Current Assets	1.0	1.0	-0.75	-0.95	0.27	-0.03		0.01	0.99	1.0	0.59	-0.15	0.63	0.97	0.97	0.51	0.96
Intangible Assets	0.01	0.0	0.05	-0.04	0.26	0.22	0.01		0.03	0.01	0.02	0.16	0.03	-0.03	-0.03	0.09	-0.02
Common Stock	0.99	0.98	-0.64	-0.97	0.3	0.0	0.99	0.03		0.99	0.61	-0.16	0.57	0.94	0.94	0.59	0.96
Net Tangible Assets	1.0	1.0	-0.7	-0.95	0.26	-0.06	1.0	0.01	0.99		0.57	-0.15	0.59	0.96	0.96	0.56	0.96
Long Term Debt	0.59	0.57	-0.43	-0.67	0.22	0.42	0.59	0.02	0.61	0.57		-0.24	0.51	0.56	0.56	0.33	0.54
Net Receivables	-0.15	-0.15	0.07	0.18	0.22	-0.05	-0.15	0.16	-0.16	-0.15	-0.24		0.18	-0.16	-0.16	-0.11	-0.17
Property Plant Equipment	0.63	0.62	-0.76	-0.58	0.46	0.16	0.63	0.03	0.57	0.59	0.51	0.18		0.67	0.66	0.15	0.58
Net Invested Capital	0.97	0.97	-0.79	-0.92	0.24	-0.08	0.97	-0.03	0.94	0.96	0.56	-0.16	0.67		1.0	0.43	0.98
Net Working Capital	0.97	0.97	-0.79	-0.92	0.24	-0.08	0.97	-0.03	0.94	0.96	0.56	-0.16	0.66	1.0		0.43	0.98
Current Deferred Revenue	0.51	0.51	-0.03	-0.52	0.29	0.04	0.51	0.09	0.59	0.56	0.33	-0.11	0.15	0.43	0.43		0.53
Capital Stock	0.96	0.96	-0.67	-0.95	0.28	-0.09	0.96	-0.02	0.96	0.96	0.54	-0.17	0.58	0.98	0.98	0.53

Click cells to compare fundamentals

About ESSA Pharma Financial Statements

ESSA Pharma investors use historical fundamental indicators, such as ESSA Pharma's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ESSA Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	171.5 M	180.1 M
Intangibles To Total Assets	0.36	0.38

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC